Evidence map›Paper›PMID 11148223›Full record

ArticleThe Journal of experimental medicine2001

The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing.

A G Brickner, E H Warren, J A Caldwell, Y Akatsuka, T N Golovina, A L Zarling, J Shabanowitz, L C Eisenlohr, D F Hunt, V H Engelhard and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 182 citations in OpenAlex.

  1. Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2009
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Rapid Multiplex Genotyping of 20 HLA-AFrontiers in immunology · 2019
    Article
  12. Review
  13. Article
  14. Review
  15. A divergent Pumilio repeat protein family for pre-rRNA processing and mRNA localization.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  16. Article
  17. Upregulated hPuf-A promotes breast cancer tumorigenesis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Article
  18. Article
  19. Review
  20. Minor histocompatibility antigens and the maternal immune response to the fetus during pregnancy.American journal of reproductive immunology (New York, N.Y. : 1989) · 2013
    Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

A G BricknerDepartment of Microbiology, Beirne B. Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA.
E H Warren
J A Caldwell
Y Akatsuka
T N Golovina
A L Zarling
J Shabanowitz
L C Eisenlohr
D F Hunt
V H Engelhard
S R Riddell
Carter Center · USUniversity of Virginia · USThomas Jefferson University · USUniversity of Washington · USFred Hutch Cancer Center · US

Funding

VIRUS-MEDIATED MYELOSUPPRESSIONP01CA018029 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Geoffrey Roger HILL · 1985 to 2026
$128.4M
Cancer Research Training Program: From Molecular Mechanisms to Therapeutic StrategiesT32CA009109 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Andrew Carl Dudley, Melanie R Rutkowski · 1985 to 2026
$13.9M
CAREER DEVELOPMENT IN PEDIATRIC AND MEDICAL ONCOLOGYK12CA076930 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DAVIDSON, NANCY ELLEN, MESHINCHI, SOHEIL · 1997 to 2025
$13.1M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007496 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Michael G. Brown, Coleen A McNamara · 1995 to 2026
$10.2M
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRYR37AI033993 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HUNT, DONALD F · 1999 to 2008
$5.6M
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRYR01AI033993 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HUNT, DONALD F · 1994 to 2017
$4.9M
SPECIFICITY OF CLASS 1 RESTRICTED ANTIGEN PROCESSINGR01AI039501 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI EISENLOHR, LAURENCE CRANE · 1997 to 2011
$3.0M
ANTIGENIC DETERMINANTS ON HLA-B7 AND -A2R01AI020963 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI ENGELHARD, VICTOR H · 1985 to 2006
$1.8M
ANTIGENIC DETERMINENTS ON HLA-B7 AND HLA-A2R37AI020963 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI ENGELHARD, VICTOR H. · 1994 to 2001
$653k
NCI NIH HHS K12 CA076930NCI NIH HHS P01 CA018029NCI NIH HHS T32 CA009109NIAID NIH HHS AI20963NIAID NIH HHS AI33993NIAID NIH HHS AI39501NIAID NIH HHS R01 AI020963NIAID NIH HHS R01 AI033993NIAID NIH HHS R01 AI039501NIAID NIH HHS R37 AI020963NIAID NIH HHS R37 AI033993NIAID NIH HHS T32 AI007496
6 · The paper itself

Abstract

Minor histocompatibility antigens (mHAgs) present a significant impediment to organ and bone marrow transplantation between HLA-identical donor and recipient pairs. Here we report the identification of a new HLA-A*0201-restricted mHAg, HA-8. Designation of this mHAg as HA-8 is based on the nomenclature of Goulmy (Goulmy, E. 1996. Curr. Opin. Immunol. 8:75-81). This peptide, RTLDKVLEV, is derived from KIAA0020, a gene of unknown function located on chromosome 9. Polymorphic alleles of KIAA0020 encode the alternative sequences PTLDKVLEV and PTLDKVLEL. Genotypic analysis demonstrated that the HA-8-specific cytotoxic T lymphocyte (CTL) clone SKH-13 recognized only cells that expressed the allele encoding R at P1. However, when PTLDKVLEV was pulsed onto cells, or when a minigene encoding this sequence was used to artificially translocate this peptide into the endoplasmic reticulum, it was recognized by CTLs nearly as well as RTLDKVLEV. This indicates that the failure of CTLs to recognize cells expressing the PTLDKVLEV-encoding allele of KIAA0020 is due to a failure of this peptide to be appropriately proteolyzed or transported. Consistent with the latter possibility, PTLDKVLEV and its longer precursors were transported poorly compared with RTLDKVLEV by transporter associated with antigen processing (TAP). These studies identify a new human mHAg and provide the first evidence that minor histocompatibility differences can result from the altered processing of potential antigens rather than differences in interaction with the relevant major histocompatibility complex molecule or T cell receptor.

Indexed as

Antigen PresentationAllelesAmino Acid SequenceBase SequenceClone CellsDNA PrimersEpitopesFemaleHumansMaleMass SpectrometryMinor Histocompatibility AntigensMolecular Sequence DataPedigreePolymorphism, GeneticReverse Transcriptase Polymerase Chain ReactionDNA PrimersEpitopesMinor Histocompatibility Antigens

Identifiers

PMID11148223
PMCPMC2193344
OpenAlexW2150211653

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.